Anbio Biotechnology Class A Ordinary Shares (NNNN) — Cash Flow Quality Index
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Cash Flow Quality Index of 0.17x as of June 2024. Operating cash flow of $647.54K is below net income of $3.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Anbio Biotechnology Class A Ordinary Sha (NNNN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Anbio Biotechnology Class A Ordinary Shares Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Anbio Biotechnology Class A Ordinary Shares across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see NNNN cash generation efficiency.
Annual Cash Flow Quality Index for Anbio Biotechnology Class A Ordinary Shares (2021–2025)
Year-by-year earnings quality comparison for Anbio Biotechnology Class A Ordinary Shares.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -1.05x | $-6.74 Million | $6.40 Million | ▼ -220.0% |
| 2024 | 0.88x | $2.08 Million | $2.37 Million | ▲ +119.9% |
| 2023 | 0.40x | $898.37K | $2.25 Million | ▼ -10.3% |
| 2022 | 0.44x | $4.45 Million | $10.01 Million | ▼ -73.0% |
| 2021 | 1.65x | $4.18 Million | $2.54 Million | — |